Company · NEO
NeoGenomics, Inc.
Name as listed on its exchange; filed with the SEC as NEOGENOMICS INC.
Nasdaq's symbol directory lists NEO on Nasdaq as “NeoGenomics, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders sold on 2 occasions ($380K); 2 filings by holders of 5% or more; 1 congressional trade disclosure; 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Aunan Greg D, Chief Accounting Officer sold $321K
- Lynn A. Tetrault sold $59K
Every trade (2)
- SELLAunan Greg D, Chief Accounting Officer sold $321K
- SELLLynn A. Tetrault sold $59K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- First Light Asset Management, LLC 7.99%
- BlackRock, Inc. 15.6%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Oct 28, 2026
- Results of operations and financial condition; Departure or appointment of directors or officers; Amendments to articles or bylaws; change in fiscal year Oct 5, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.